Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock. Bio-Path Stock Performance NASDAQ BPTH opened at $0.18 on Tuesday. The business’s fifty day simple moving average is $0.16 and its 200-day […]
More Stories
Age of Attraction Season 2? Renewal, Couples, Release Date, and Trailer
After a positive review of the debut of season 1 on March 11, 2026, people are craving more for the...
‘Bob’s Burgers’ Actor Identified as Driver Rescued From Fiery New Hampshire Crash
By Haika Mrema Actor and comedian Eugene Mirman has been identified as the driver rescued from a burning vehicle following...
Trump Says Pam Bondi Is out as His Attorney General
By Matthew Vadum President Donald Trump said on April 2 that Pam Bondi will no longer be the U.S. attorney...
US Military Says More Than 12,300 Iranian Targets Struck So Far
By Jack Phillips The U.S. military has provided an operational update on the month-long war with Iran, announcing that more...
What to Expect from the March Jobs Report
By Andrew Moran The March jobs report, scheduled for release on April 3, will mark the end of a quarter...
Russia Bans Producers From Exporting Gasoline
By Guy Birchall Russia extended a temporary ban on gasoline exports to producers, Moscow said on April 2, citing the...